ResearcherHumanitas UniversityActive in the last 2 years
Raffaele De Luca
Matched on ORCID iD 0000-0002-9337-0769; OpenAlex author ID A5026787538, A5112897347. Sources: OpenAlex.
Their work
- Papers
- 6
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 48
2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 4 papers
Papers 6
- Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. Co-author DOI 10.1001/jamanetworkopen.2026.35610↗
- Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreatic Cancer. Co-author DOI 10.1002/ueg2.70187↗
- Nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil for metastatic pancreatic ductal adenocarcinoma following gemcitabine-b… Co-author DOI 10.1007/s10585-026-10401-5↗
- Hereditary pancreatic cancer: A proposal for surveillance from the Italian Association for the Study of the Pancreas (AISP). Co-author DOI 10.1016/j.dld.2026.04.007↗
- Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant treatment. Co-author DOI 10.1016/j.ejso.2022.12.006↗
- Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Interobserver Agreement on NCCN Resectabili… Co-author DOI 10.1097/as9.0000000000000087↗
Closest collaborators
The 25 strongest of 48 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Salvatore Paiella · 4 shared papers, 2023–2026 · strength 0.88
- Paper Hereditary pancreatic cancer: A proposal for surveillance from the Italian Association for the Study of the Pancreas (A… DOI 10.1016/j.dld.2026.04.007↗
- Paper Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreati… DOI 10.1002/ueg2.70187↗
- Paper Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. DOI 10.1001/jamanetworkopen.2026.35610↗
- Erica Secchettin · 3 shared papers, 2026 · strength 0.73
- Paper Hereditary pancreatic cancer: A proposal for surveillance from the Italian Association for the Study of the Pancreas (A… DOI 10.1016/j.dld.2026.04.007↗
- Paper Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreati… DOI 10.1002/ueg2.70187↗
- Paper Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. DOI 10.1001/jamanetworkopen.2026.35610↗
- Lívia Archibugi · 3 shared papers, 2026 · strength 0.73
- Paper Hereditary pancreatic cancer: A proposal for surveillance from the Italian Association for the Study of the Pancreas (A… DOI 10.1016/j.dld.2026.04.007↗
- Paper Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreati… DOI 10.1002/ueg2.70187↗
- Paper Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. DOI 10.1001/jamanetworkopen.2026.35610↗
- Massimo Falconi · 4 shared papers, 2021–2026 · strength 0.62
- Paper Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreati… DOI 10.1002/ueg2.70187↗
- Paper Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. DOI 10.1001/jamanetworkopen.2026.35610↗
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Roberto Salvia · 4 shared papers, 2021–2026 · strength 0.62
- Paper Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreati… DOI 10.1002/ueg2.70187↗
- Paper Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. DOI 10.1001/jamanetworkopen.2026.35610↗
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Silvia Carrara · 2 shared papers, 2026 · strength 0.54
- Paper Hereditary pancreatic cancer: A proposal for surveillance from the Italian Association for the Study of the Pancreas (A… DOI 10.1016/j.dld.2026.04.007↗
- Paper Presumed Intraductal Papillary Mucinous Neoplasms in Individuals at High Risk for Pancreatic Cancer. DOI 10.1001/jamanetworkopen.2026.35610↗
- Alessandro Zerbi · 3 shared papers, 2021–2026 · strength 0.44
- Paper Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreati… DOI 10.1002/ueg2.70187↗
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Paper Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Int… DOI 10.1097/as9.0000000000000087↗
- Oronzo Brunetti · 2 shared papers, 2023–2026 · strength 0.42
- Paper Nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil for metastatic pancreatic ducta… DOI 10.1007/s10585-026-10401-5↗
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Marta Puzzono · 2 shared papers, 2026 · strength 0.37
- Giuliana Sereni · 2 shared papers, 2026 · strength 0.37
- Arianna Dal Buono · 2 shared papers, 2026 · strength 0.37
- Giulia Martina Cavestro · 2 shared papers, 2026 · strength 0.37
- Gabriele Capurso · 2 shared papers, 2026 · strength 0.37
- Paolo Giorgio Arcidiacono · 2 shared papers, 2026 · strength 0.37
- Giuseppe Malleo · 2 shared papers, 2021–2026 · strength 0.29
- Paper Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreati… DOI 10.1002/ueg2.70187↗
- Paper Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Int… DOI 10.1097/as9.0000000000000087↗
- Elsa Vitale · 1 shared paper, 2026 · strength 0.27
- Luca Vittorio Gianotti · 2 shared papers, 2021–2023 · strength 0.24
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Paper Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Int… DOI 10.1097/as9.0000000000000087↗
- Ugo Boggi · 2 shared papers, 2021–2023 · strength 0.24
- Paper Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS® and neoadjuvant tre… DOI 10.1016/j.ejso.2022.12.006↗
- Paper Resectability of Pancreatic Cancer Is in the Eye of the Observer: A Multicenter, Blinded, Prospective Assessment of Int… DOI 10.1097/as9.0000000000000087↗
- Matteo De Pastena · 1 shared paper, 2026 · strength 0.20
- Cecilia Binda · 1 shared paper, 2026 · strength 0.20
- Gaetano Lauri · 1 shared paper, 2026 · strength 0.20
- Francesco DE COBELLI · 1 shared paper, 2026 · strength 0.20
- Luigi Laghi · 1 shared paper, 2026 · strength 0.20
- Gabriella Lionetto Lionetto · 1 shared paper, 2026 · strength 0.20
- Carrara Silvia · 1 shared paper, 2026 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.